IRCT20211203053263N1已完成3 期
Comparison of Bosentan with routine protocol on outcomes of high-risk outpatients with COVID-19 infection.
Ilam University of Medical Sciences0 个研究点目标入组 350 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •One or more symptoms of COVID-19 illness and laboratory-confirmed SARS-CoV-2 determined by PCR assay < 72 hours prior to randomization
- •Has at least one CDC defined risk factor for severe COVID-19 illness
- •Clinical team deems stable for outpatient management without supplemental oxygen
- •Has informed consent
- •women of child bearing potential must agree to use at least one primary form of contraception for the duration of the study
排除标准
- •Pregnancy or Lactation
- •Glibenclamide Consumption
- •Cyclosporine Consumption
- •Aminotransferases > 3 times normal
- •Allergy to bosentan
研究者
相似试验
已完成
3 期
Bosentan in hospitalized patients with COVID-19 infectioCOVID-19.COVID-19, virus identifiedU07.1IRCT20211203053263N2Ilam University of Medical Sciences200
招募中
2 期
The effect of Bosentan in the treatment of pulmonary hypertension in patients with COVID-19Condition 1: COVID-19. Condition 2: COVID-19.COVID-19, virus not identifiedCOVID-19, virus identifiedU07.2U07.1IRCT20210710051831N1Qazvin University of Medical Sciences60
已完成
不适用
Study on the effect of Bosentan on trophic skin lesions in diabetic fOOT Syndrome (BOOTS)Diabetic foot syndromeNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusISRCTN51795022niversity Hospital Zürich (Switzerland)20
招募中
不适用
Clinical investigation to examine the effect of bone formation of PTH on multilevel spinal implant surgery for vertebral degenerative disease associated with osteoporosisVertebral degeneration associated with OsteoporosisJPRN-UMIN0000152021.University of Yamanashi2.Hamamatsu University School of Medicine3.Shinshu University, School of Medicine1-3Department of Orthopaedic Surgery160
已完成
1 期
Management of osteoporosis with Bonton active granulesCTRI/2016/04/006832Vasu Research Centre VRC60